To evaluate the efficacy of fibrin glue as a primary treatment for pilonidal sinus disease (PSD) compared to traditional methods.
Key Findings:
Fibrin glue treatment resulted in a high patient satisfaction rate (X%).
Patients experienced a rapid return to normal activities with no requirement for aftercare.
The treatment demonstrated significant cost benefits compared to other techniques (X% savings).
Interpretation:
Fibrin glue is a promising minimally invasive option for treating PSD, offering effective outcomes with minimal recovery time and patient burden, potentially changing clinical practice.
Limitations:
The study lacks data on larger patient populations.
Long-term outcomes beyond one year were not assessed.
Potential biases due to the single-surgeon study design.
Conclusion:
Fibrin glue is an effective and efficient treatment for primary and recurrent pilonidal sinus disease, providing a high cure rate with minimal tissue loss and quick recovery, but further studies are needed to validate these findings.
